Long Non-coding RNA MALAT1 Alleviates the Elevated Intraocular Pressure (Eiop)-induced Glaucoma Progression via Sponging miR-149-5p

References

• Kimura A, Namekata K, Guo X, Harada C, Harada T. Dock3-NMDA receptor interaction as a target for glaucoma therapy. Histol Histopathol. 2017;32:215–21.
   PubMed Web of Science ®Google Scholar
• Marcus MW, Müskens RP, Ramdas WD, Wolfs RC, De Jong PT, Vingerling JR, Hofman A, Stricker BH, Jansonius NM. Cholesterol-lowering drugs and incident open-angle glaucoma: a population-based cohort study. PloS One. 2012;7(1):e29724. doi:10.1371/journal.pone.0029724.
   PubMed Web of Science ®Google Scholar
• Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol. 2002;120(10):1268–79. doi:10.1001/archopht.120.10.1268.
   PubMed Web of Science ®Google Scholar
• Hysi PG, Cheng CY, Springelkamp H, Macgregor S, Bailey JNC, Wojciechowski R, Vitart V, Nag A, Hewitt AW, Höhn R, et al. Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucoma. Nat Genet. 2014;46(10):1126–30. doi:10.1038/ng.3087.
   PubMed Web of Science ®Google Scholar
• Al-Mahmood AM, Al-Swailem SA, Edward DP. Glaucoma and corneal transplant procedures. J Ophthalmol. 2012;2012:576394. doi:10.1155/2012/576394.
   PubMed Web of Science ®Google Scholar
• Musch DC, Gillespie BW, Niziol LM, Lichter PR, Varma R. Intraocular pressure control and long-term visual field loss in the collaborative initial glaucoma treatment study. Ophthalmology. 2011;118(9):1766–73. doi:10.1016/j.ophtha.2011.01.047.
   PubMed Web of Science ®Google Scholar
• Liu Y, Allingham RR. Molecular genetics in glaucoma. Exp Eye Res. 2011;93(4):331–39. doi:10.1016/j.exer.2011.08.007.
   PubMed Web of Science ®Google Scholar
• Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861–74. doi:10.1038/nrg3074.
   PubMed Web of Science ®Google Scholar
• Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 2014;1839(11):1097–109. doi:10.1016/j.bbagrm.2014.08.012.
   PubMed Web of Science ®Google Scholar
• Gong W, Li J, Zhu G, Wang Y, Zheng G, Kan Q. Chlorogenic acid relieved oxidative stress injury in retinal ganglion cells through IncRNA-TUG1/Nrf2. Cell Cycle (Georgetown, Tex). 2019;undefined:1–11.
   Google Scholar
• Xu Y, Xing YQ. Long non-coding RNA GAS5 contributed to the development of glaucoma via regulating the TGF-β signaling pathway. Eur Rev Med Pharmacol Sci. 2018;22:896–902.
   PubMed Web of Science ®Google Scholar
• Zhang B, Arun G, Mao YS, Lazar Z, Hung G, Bhattacharjee G, Xiao X, Booth C, Wu J, Zhang C. The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. Cell Rep. 2012;2(1):111–23. doi:10.1016/j.celrep.2012.06.003.
   PubMed Web of Science ®Google Scholar
• Xia D, Sui R, Zhang Z. Administration of resveratrol improved Parkinson’s disease-like phenotype by suppressing apoptosis of neurons via modulating the MALAT1/miR-129/SNCA signaling pathway. J Cell Biochem. 2019;120(4):4942–51. doi:10.1002/jcb.27769.
   PubMed Web of Science ®Google Scholar
• Zhang QS, Wang ZH, Zhang JL, Duan YL, Li GF, Zheng DL. Beta-asarone protects against MPTP-induced Parkinson’s disease via regulating long non-coding RNA MALAT1 and inhibiting α-synuclein protein expression. Biomed Pharmacother. 2016;83:153–59. doi:10.1016/j.biopha.2016.06.017.
   PubMed Web of Science ®Google Scholar
• Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 2006;20(5):515–24. doi:10.1101/gad.1399806.
   PubMed Web of Science ®Google Scholar
• Jin L, Li Y, Liu J, Yang S, Gui Y, Mao X, Nie G, Lai Y. Tumor suppressor miR-149-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma. Mol Med Rep. 2016;13(6):5386–92. doi:10.3892/mmr.2016.5205.
   PubMed Web of Science ®Google Scholar
• Chen W, Zhang J, Xu H, Dai J, Zhang X. The negative regulation of miR-149-5p in melanoma cell survival and apoptosis by targeting LRIG2. Am J Transl Res. 2017;9:4331–40.
   PubMed Web of Science ®Google Scholar
• Tian P, Yan L. Inhibition of microRNA-149-5p induces apoptosis of acute myeloid leukemia cell line THP-1 by targeting fas ligand (FASLG). Med Sci Monit. 2016;22:5116–23. doi:10.12659/MSM.899114.
   PubMed Web of Science ®Google Scholar
• Nie XG, Fan DS, Huang YX, He YY, Dong BL, Gao F. Downregulation of microRNA-149 in retinal ganglion cells suppresses apoptosis through activation of the PI3K/Akt signaling pathway in mice with glaucoma. Am J Physiol Cell Physiol. 2018;315(6):C839–C49. doi:10.1152/ajpcell.00324.2017.
   PubMed Web of Science ®Google Scholar
• Zhou RR, Li HB, You QS, Rong R, You ML, Xiong K, Huang JF, Xia XB, Ji D. Silencing of GAS5 alleviates glaucoma in rat models by reducing retinal ganglion cell apoptosis. Hum Gene Ther. 2019;30(12):1505–19. doi:10.1089/hum.2019.056.
   PubMed Web of Science ®Google Scholar
• Liu H, Anders F, Thanos S, Mann C, Liu A, Grus FH, Pfeiffer N, Prokosch-Willing V. Hydrogen sulfide protects retinal ganglion cells against glaucomatous injury in vitro and in vivo. Invest Ophthalmol Vis Sci. 2017;58(12):5129–41. doi:10.1167/iovs.17-22200.
   PubMed Web of Science ®Google Scholar
• Sappington RM, Chan M, Calkins DJ. Interleukin-6 protects retinal ganglion cells from pressure-induced death. Invest Ophthalmol Vis Sci. 2006;47(7):2932–42. doi:10.1167/iovs.05-1407.
   PubMed Web of Science ®Google Scholar
• Lauzi J, Anders F, Liu H, Pfeiffer N, Grus F, Thanos S, Arnhold S, Prokosch V. Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma. PLoS One. 2019;14(1):e0207190. doi:10.1371/journal.pone.0207190.
   PubMed Web of Science ®Google Scholar
• Zaninello M, Scorrano L. Rapidly purified ganglion cells from neonatal mouse retinas allow studies of mitochondrial morphology and autophagy. Pharmacol Res. 2018;138:16–24. doi:10.1016/j.phrs.2018.07.024.
   PubMed Web of Science ®Google Scholar
• Kobayashi W, Onishi A, Tu HY, Takihara Y, Matsumura M, Tsujimoto K, Inatani M, Nakazawa T, Takahashi M. Culture systems of dissociated mouse and human pluripotent stem cell-derived retinal ganglion cells purified by two-step immunopanning. Invest Ophthalmol Vis Sci. 2018;59(2):776–87. doi:10.1167/iovs.17-22406.
   PubMed Web of Science ®Google Scholar
• Barres BA, Silverstein BE, Corey DP, Chun LL. Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning. Neuron. 1988;1(9):791–803. doi:10.1016/0896-6273(88)90127-4.
   PubMed Web of Science ®Google Scholar
• Karch J, Molkentin JD. Regulated necrotic cell death: the passive aggressive side of Bax and Bak. Circ Res. 2015;116(11):1800–09. doi:10.1161/CIRCRESAHA.116.305421.
   PubMed Web of Science ®Google Scholar
• Levkovitch-Verbin H. Retinal ganglion cell apoptotic pathway in glaucoma: initiating and downstream mechanisms. Prog Brain Res. 2015;220:37–57.
   PubMed Web of Science ®Google Scholar
• Li HB, You QS, Xu LX, Sun LX, Abdul Majid AS, Xia XB, Ji D. Long non-coding RNA-MALAT1 mediates retinal ganglion cell apoptosis through the PI3K/Akt signaling pathway in rats with glaucoma. Cell Physiol Biochem. 2017;43:2117–32.
   PubMedGoogle Scholar
• Hassan B, Akcakanat A, Holder AM, Meric-Bernstam F. Targeting the PI3-kinase/Akt/mTOR signaling pathway. Surg Oncol Clin N Am. 2013;22(4):641–64. doi:10.1016/j.soc.2013.06.008.
   PubMed Web of Science ®Google Scholar